热门资讯> 正文
Coeptis Therapeutics、Z Squared宣布合并协议
2025-04-25 21:08
- Coeptis Therapeutics (NASDAQ:COEP) and Z Squared have entered into a definitive merger agreement that will result in Z Squared becoming a wholly-owned subsidiary of Coeptis.
- Under the terms of the merger agreement, a wholly-owned subsidiary of Coeptis will merge with and into Z Squared and the holders of the outstanding Z Squared shares will receive equity in Coeptis in exchange for 9,000 U.S. based dogecoin mining machines at closing.
- The combined company will focus on advancing Z Squared’s digital asset mining expertise, which focuses primarily on generating Dogecoin along with other digital assets. It will be led by Z Squared executives, David Halabu as chief executive officer and Michelle Burke as chief operating officer.
- In connection with the merger, Coeptis intends to spin out its biopharmaceutical operations, and continue to operate those operations separately.
- Source: Press Release
More on Coeptis Therapeutics
- Financial information for Coeptis Therapeutics Holdings, Inc.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
